Follow the 엔젠바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엔젠바이오 has recorded 86 reports. Market capitalisation: €21.5bn. The latest transaction was reported on 10 July 2026 (Other). Among the most active insiders: 최대출. The full history is accessible without an account.
81
Insider Decl.
n/a
Thresholds
n/a
27 ops.
Buy Volume
n/a
21 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,492 of 29,063 companies
9.8
score / 100
Value
6
Quality
13
FCF yld-45%
Earn yld-29%
EV/EBITDA·
ROE-29%
Gross mgn18%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.